A study to compare giving tranexamic acid all at once versus giving it in two parts to people having brain tumour surgery to see which way works better for stopping bleeding
Phase 3
- Registration Number
- CTRI/2024/05/067553
- Lead Sponsor
- Vardhaman Mahavir Medical College and Safdarjung Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adult patients aged 18 to 65 years undergoing brain tumour surgery
2. American Society of Anaesthesiologists (ASA) grade I and II only
Exclusion Criteria
1. Patients who have a history of allergic reaction to tranexamic acid
2. Patients having previous documented history of thromboembolic disease
3. Patients who have documented coagulopathies diagnosed before surgery
4. Patients with documented hepatic or renal dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of blood loss during surgery in millilitres <br/ ><br>Timepoint: At the end of surgery i.e. skin closure has finished
- Secondary Outcome Measures
Name Time Method Blood loss during surgery <br/ ><br>Timepoint: Every hourly starting from time of incision till completion of surgery i.e. skin closure completed